Delivery Order SPE2DR25D1041-SPE2DR26FHR5E
Award Date 2/3/26
Potential Completion Date 2/4/26
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,667.95 delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement medication. This competitively awarded, firm fixed-price delivery order was issued on January 5, 2026, with a completion date of January 6, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for 36,000 units of Creon DR 100s capsules, valued at $2,704.53. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of December 12, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,135.11 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancrelipase) in 100-count bottles on January 15, 2026, with completion expected by January 16, 2026. This non-set-aside, firm fixed-price delivery order was performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small task order under AmerisourceBergen's larger pharmaceutical supply framework supporting military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles, valued at $9,164.04. This competitively awarded, firm fixed-price delivery order, with no set-aside designation, is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order valued at $5,220.99 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) on January 22, 2026, with an ultimate completion date of January 23, 2026. The award was made on a firm fixed-price basis without set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's...
- The Defense Logistics Agency awarded a delivery order valued at $5,939.74 to Amerisourcebergen Drug Corp for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement therapy commonly prescribed for patients with pancreatic insufficiency. The award was made on January 27, 2026, with an ultimate completion date of January 28, 2026, and represents a firm fixed-price contract with no set-aside designation. The order will be fulfilled from the awardee's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $19,641.44 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100-strength capsules on January 7, 2026, with completion scheduled for January 8, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order fulfills medical supply needs for federal healthcare systems, including military treatment facilities...
- The Defense Logistics Agency awarded a delivery order valued at $27,202.55 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $3,088.91 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100 mg capsules. This non-competitive, firm fixed price delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child contract under a larger vehicle, this delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,982.70 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, a pancreatic enzyme replacement therapy. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement with an ultimate completion date of December 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and serve as the prime contractor for this...